'en:brimonidine tartrate'
(id=7012314 ; fe=en:brimonidine tartrate ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=2792 creation date=2017-06-25 touchdate=2025-07-16 16:21:30.000) ≈ 71 relations sortantes
- en:brimonidine tartrate --
r_associated #0: 29 / 1 ->
en:agonists
n1=en:brimonidine tartrate | n2=en:agonists | rel=r_associated | relid=0 | w=29
- en:brimonidine tartrate --
r_associated #0: 29 / 1 ->
en:brimonidine tartrate 2 mg/ml ophthalmic solution [alphagan]
n1=en:brimonidine tartrate | n2=en:brimonidine tartrate 2 mg/ml ophthalmic solution [alphagan] | rel=r_associated | relid=0 | w=29
- en:brimonidine tartrate --
r_associated #0: 29 / 1 ->
en:immunology aspects
n1=en:brimonidine tartrate | n2=en:immunology aspects | rel=r_associated | relid=0 | w=29
- en:brimonidine tartrate --
r_associated #0: 29 / 1 ->
en:mechanism of action qualifier
n1=en:brimonidine tartrate | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=29
- en:brimonidine tartrate --
r_associated #0: 28 / 0.966 ->
en:brimonidine tartrate 2 mg/ml
n1=en:brimonidine tartrate | n2=en:brimonidine tartrate 2 mg/ml | rel=r_associated | relid=0 | w=28
- en:brimonidine tartrate --
r_associated #0: 28 / 0.966 ->
en:therapeutic use - qualifier
n1=en:brimonidine tartrate | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=28
- en:brimonidine tartrate --
r_associated #0: 27 / 0.931 ->
en:guanabenz
n1=en:brimonidine tartrate | n2=en:guanabenz | rel=r_associated | relid=0 | w=27
- en:brimonidine tartrate --
r_associated #0: 26 / 0.897 ->
en:exposure as collected domain
n1=en:brimonidine tartrate | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=26
- en:brimonidine tartrate --
r_associated #0: 25 / 0.862 ->
en:brimonidine
n1=en:brimonidine tartrate | n2=en:brimonidine | rel=r_associated | relid=0 | w=25
- en:brimonidine tartrate --
r_associated #0: 25 / 0.862 ->
en:propylhexedrine
n1=en:brimonidine tartrate | n2=en:propylhexedrine | rel=r_associated | relid=0 | w=25
- en:brimonidine tartrate --
r_associated #0: 23 / 0.793 ->
en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension
n1=en:brimonidine tartrate | n2=en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension | rel=r_associated | relid=0 | w=23
- en:brimonidine tartrate --
r_associated #0: 23 / 0.793 ->
en:detomidine hydrochloride
n1=en:brimonidine tartrate | n2=en:detomidine hydrochloride | rel=r_associated | relid=0 | w=23
- en:brimonidine tartrate --
r_associated #0: 23 / 0.793 ->
en:methoxamine hydrochloride
n1=en:brimonidine tartrate | n2=en:methoxamine hydrochloride | rel=r_associated | relid=0 | w=23
- en:brimonidine tartrate --
r_associated #0: 23 / 0.793 ->
en:quinoxalines
n1=en:brimonidine tartrate | n2=en:quinoxalines | rel=r_associated | relid=0 | w=23
- en:brimonidine tartrate --
r_associated #0: 23 / 0.793 ->
en:racephedrine
n1=en:brimonidine tartrate | n2=en:racephedrine | rel=r_associated | relid=0 | w=23
- en:brimonidine tartrate --
r_associated #0: 21 / 0.724 ->
en:pharmacokinetic aspects
n1=en:brimonidine tartrate | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=21
- en:brimonidine tartrate --
r_associated #0: 21 / 0.724 ->
en:standards characteristics
n1=en:brimonidine tartrate | n2=en:standards characteristics | rel=r_associated | relid=0 | w=21
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
allergie à un médicament
n1=en:brimonidine tartrate | n2=allergie à un médicament | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
allergie aux médicaments
n1=en:brimonidine tartrate | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
allergie médicamenteuse
n1=en:brimonidine tartrate | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
carbadox
n1=en:brimonidine tartrate | n2=carbadox | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
chlorhydrate de xylazine
n1=en:brimonidine tartrate | n2=chlorhydrate de xylazine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
échinomycine
n1=en:brimonidine tartrate | n2=échinomycine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:6-cyano-7-nitroquinoxaline-2,3-dione
n1=en:brimonidine tartrate | n2=en:6-cyano-7-nitroquinoxaline-2,3-dione | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:adrenergic alpha-1 receptor agonists
n1=en:brimonidine tartrate | n2=en:adrenergic alpha-1 receptor agonists | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:adrenergic alpha2-agonists [moa]
n1=en:brimonidine tartrate | n2=en:adrenergic alpha2-agonists [moa] | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:alpha-2 adrenergic receptor agonist (disposition)
n1=en:brimonidine tartrate | n2=en:alpha-2 adrenergic receptor agonist (disposition) | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:anthrax vaccine adsorbed
n1=en:brimonidine tartrate | n2=en:anthrax vaccine adsorbed | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:biotin-containing product
n1=en:brimonidine tartrate | n2=en:biotin-containing product | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:bluefish allergenic extract
n1=en:brimonidine tartrate | n2=en:bluefish allergenic extract | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:bos taurus hip joint preparation
n1=en:brimonidine tartrate | n2=en:bos taurus hip joint preparation | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:brimonidine + timolol
n1=en:brimonidine tartrate | n2=en:brimonidine + timolol | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:brimonidine 0.0033 mg/mg topical gel [mirvaso]
n1=en:brimonidine tartrate | n2=en:brimonidine 0.0033 mg/mg topical gel [mirvaso] | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension [simbrinza]
n1=en:brimonidine tartrate | n2=en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension [simbrinza] | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:brimonidine tartrate 2 mg/ml / timolol 5 mg/ml ophthalmic solution [combigan]
n1=en:brimonidine tartrate | n2=en:brimonidine tartrate 2 mg/ml / timolol 5 mg/ml ophthalmic solution [combigan] | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:brimonidine tartrate 2 mg/ml ophthalmic solution
n1=en:brimonidine tartrate | n2=en:brimonidine tartrate 2 mg/ml ophthalmic solution | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:brimonidine tartrate 5 mg/ml
n1=en:brimonidine tartrate | n2=en:brimonidine tartrate 5 mg/ml | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:carbadox
n1=en:brimonidine tartrate | n2=en:carbadox | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:central alpha-adrenoceptor agonist
n1=en:brimonidine tartrate | n2=en:central alpha-adrenoceptor agonist | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:cirazoline
n1=en:brimonidine tartrate | n2=en:cirazoline | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:clonazoline
n1=en:brimonidine tartrate | n2=en:clonazoline | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:combigan
n1=en:brimonidine tartrate | n2=en:combigan | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:coumazoline
n1=en:brimonidine tartrate | n2=en:coumazoline | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:decreased intraocular fluid pressure
n1=en:brimonidine tartrate | n2=en:decreased intraocular fluid pressure | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:detomidine
n1=en:brimonidine tartrate | n2=en:detomidine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:dimetofrine
n1=en:brimonidine tartrate | n2=en:dimetofrine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:drug allergy
n1=en:brimonidine tartrate | n2=en:drug allergy | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:echinomycin
n1=en:brimonidine tartrate | n2=en:echinomycin | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:fda established names and unique ingredient identifier codes terminology
n1=en:brimonidine tartrate | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:fenoxazoline
n1=en:brimonidine tartrate | n2=en:fenoxazoline | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:flutonidine
n1=en:brimonidine tartrate | n2=en:flutonidine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:gepefrine
n1=en:brimonidine tartrate | n2=en:gepefrine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:indanazoline
n1=en:brimonidine tartrate | n2=en:indanazoline | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:indanidine
n1=en:brimonidine tartrate | n2=en:indanidine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:metaraminol
n1=en:brimonidine tartrate | n2=en:metaraminol | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:methyldopate
n1=en:brimonidine tartrate | n2=en:methyldopate | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:metizoline
n1=en:brimonidine tartrate | n2=en:metizoline | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:mivazerol
n1=en:brimonidine tartrate | n2=en:mivazerol | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:naphazoline hydrochloride
n1=en:brimonidine tartrate | n2=en:naphazoline hydrochloride | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:norepinephrine, dl-
n1=en:brimonidine tartrate | n2=en:norepinephrine, dl- | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:octodrine
n1=en:brimonidine tartrate | n2=en:octodrine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:prednazoline
n1=en:brimonidine tartrate | n2=en:prednazoline | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:simbrinza
n1=en:brimonidine tartrate | n2=en:simbrinza | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:tiamenidine
n1=en:brimonidine tartrate | n2=en:tiamenidine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:tiamenidine hydrochloride
n1=en:brimonidine tartrate | n2=en:tiamenidine hydrochloride | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:tolonidine
n1=en:brimonidine tartrate | n2=en:tolonidine | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:xylazine hydrochloride
n1=en:brimonidine tartrate | n2=en:xylazine hydrochloride | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
en:xylometazoline hydrochloride
n1=en:brimonidine tartrate | n2=en:xylometazoline hydrochloride | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
guanabenz
n1=en:brimonidine tartrate | n2=guanabenz | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
métaraminol
n1=en:brimonidine tartrate | n2=métaraminol | rel=r_associated | relid=0 | w=20
- en:brimonidine tartrate --
r_associated #0: 20 / 0.69 ->
propylhexédrine
n1=en:brimonidine tartrate | n2=propylhexédrine | rel=r_associated | relid=0 | w=20
| ≈ 75 relations entrantes
- en:drug allergy ---
r_associated #0: 115 -->
en:brimonidine tartrate
n1=en:drug allergy | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=115
- allergie aux médicaments ---
r_associated #0: 112 -->
en:brimonidine tartrate
n1=allergie aux médicaments | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=112
- allergie médicamenteuse ---
r_associated #0: 107 -->
en:brimonidine tartrate
n1=allergie médicamenteuse | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=107
- allergie à un médicament ---
r_associated #0: 100 -->
en:brimonidine tartrate
n1=allergie à un médicament | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=100
- métaraminol ---
r_associated #0: 86 -->
en:brimonidine tartrate
n1=métaraminol | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=86
- en:metaraminol ---
r_associated #0: 82 -->
en:brimonidine tartrate
n1=en:metaraminol | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=82
- échinomycine ---
r_associated #0: 65 -->
en:brimonidine tartrate
n1=échinomycine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=65
- en:echinomycin ---
r_associated #0: 63 -->
en:brimonidine tartrate
n1=en:echinomycin | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=63
- en:propylhexedrine ---
r_associated #0: 51 -->
en:brimonidine tartrate
n1=en:propylhexedrine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=51
- propylhexédrine ---
r_associated #0: 50 -->
en:brimonidine tartrate
n1=propylhexédrine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=50
- en:brimonidine + timolol ---
r_associated #0: 43 -->
en:brimonidine tartrate
n1=en:brimonidine + timolol | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=43
- en:guanabenz ---
r_associated #0: 41 -->
en:brimonidine tartrate
n1=en:guanabenz | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=41
- en:prednazoline ---
r_associated #0: 40 -->
en:brimonidine tartrate
n1=en:prednazoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=40
- en:methoxamine hydrochloride ---
r_associated #0: 39 -->
en:brimonidine tartrate
n1=en:methoxamine hydrochloride | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=39
- guanabenz ---
r_associated #0: 37 -->
en:brimonidine tartrate
n1=guanabenz | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=37
- en:anthrax vaccine adsorbed ---
r_associated #0: 36 -->
en:brimonidine tartrate
n1=en:anthrax vaccine adsorbed | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=36
- en:bluefish allergenic extract ---
r_associated #0: 35 -->
en:brimonidine tartrate
n1=en:bluefish allergenic extract | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=35
- en:cirazoline ---
r_associated #0: 35 -->
en:brimonidine tartrate
n1=en:cirazoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=35
- en:clonazoline ---
r_associated #0: 35 -->
en:brimonidine tartrate
n1=en:clonazoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=35
- en:therapeutic use - qualifier ---
r_associated #0: 35 -->
en:brimonidine tartrate
n1=en:therapeutic use - qualifier | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=35
- en:brimonidine tartrate 2 mg/ml ophthalmic solution ---
r_associated #0: 34 -->
en:brimonidine tartrate
n1=en:brimonidine tartrate 2 mg/ml ophthalmic solution | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=34
- en:combigan ---
r_associated #0: 34 -->
en:brimonidine tartrate
n1=en:combigan | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=34
- en:detomidine hydrochloride ---
r_associated #0: 34 -->
en:brimonidine tartrate
n1=en:detomidine hydrochloride | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=34
- en:immunology aspects ---
r_associated #0: 32 -->
en:brimonidine tartrate
n1=en:immunology aspects | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=32
- en:pharmacokinetic aspects ---
r_associated #0: 32 -->
en:brimonidine tartrate
n1=en:pharmacokinetic aspects | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=32
- en:racephedrine ---
r_associated #0: 32 -->
en:brimonidine tartrate
n1=en:racephedrine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=32
- chlorhydrate de xylazine ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=chlorhydrate de xylazine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- en:central alpha-adrenoceptor agonist ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=en:central alpha-adrenoceptor agonist | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- en:gepefrine ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=en:gepefrine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- en:indanidine ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=en:indanidine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- en:metizoline ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=en:metizoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- en:naphazoline hydrochloride ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=en:naphazoline hydrochloride | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- en:tolonidine ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=en:tolonidine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- en:xylazine hydrochloride ---
r_associated #0: 31 -->
en:brimonidine tartrate
n1=en:xylazine hydrochloride | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=31
- carbadox ---
r_associated #0: 30 -->
en:brimonidine tartrate
n1=carbadox | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=30
- en:agonists ---
r_associated #0: 30 -->
en:brimonidine tartrate
n1=en:agonists | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=30
- en:brimonidine 0.0033 mg/mg topical gel [mirvaso] ---
r_associated #0: 30 -->
en:brimonidine tartrate
n1=en:brimonidine 0.0033 mg/mg topical gel [mirvaso] | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=30
- en:carbadox ---
r_associated #0: 30 -->
en:brimonidine tartrate
n1=en:carbadox | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=30
- en:decreased intraocular fluid pressure ---
r_associated #0: 30 -->
en:brimonidine tartrate
n1=en:decreased intraocular fluid pressure | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=30
- en:flutonidine ---
r_associated #0: 30 -->
en:brimonidine tartrate
n1=en:flutonidine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=30
- en:brimonidine tartrate 2 mg/ml ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:brimonidine tartrate 2 mg/ml | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension [simbrinza] ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension [simbrinza] | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:brimonidine tartrate 5 mg/ml ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:brimonidine tartrate 5 mg/ml | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:detomidine ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:detomidine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:exposure as collected domain ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:exposure as collected domain | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:octodrine ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:octodrine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:standards characteristics ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:standards characteristics | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:tiamenidine hydrochloride ---
r_associated #0: 29 -->
en:brimonidine tartrate
n1=en:tiamenidine hydrochloride | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=29
- en:fda established names and unique ingredient identifier codes terminology ---
r_associated #0: 28 -->
en:brimonidine tartrate
n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=28
- en:fenoxazoline ---
r_associated #0: 28 -->
en:brimonidine tartrate
n1=en:fenoxazoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=28
- en:methyldopate ---
r_associated #0: 28 -->
en:brimonidine tartrate
n1=en:methyldopate | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=28
- en:quinoxalines ---
r_associated #0: 28 -->
en:brimonidine tartrate
n1=en:quinoxalines | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=28
- en:xylometazoline hydrochloride ---
r_associated #0: 28 -->
en:brimonidine tartrate
n1=en:xylometazoline hydrochloride | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=28
- en:adrenergic alpha-1 receptor agonists ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:adrenergic alpha-1 receptor agonists | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:adrenergic alpha2-agonists [moa] ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:adrenergic alpha2-agonists [moa] | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:alpha-2 adrenergic receptor agonist (disposition) ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:alpha-2 adrenergic receptor agonist (disposition) | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:brimonidine tartrate 2 mg/ml / brinzolamide 10 mg/ml ophthalmic suspension | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:brimonidine tartrate 2 mg/ml ophthalmic solution [alphagan] ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:brimonidine tartrate 2 mg/ml ophthalmic solution [alphagan] | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:coumazoline ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:coumazoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:dimetofrine ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:dimetofrine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:indanazoline ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:indanazoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:mechanism of action qualifier ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:mechanism of action qualifier | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:mivazerol ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:mivazerol | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:simbrinza ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:simbrinza | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:tiamenidine ---
r_associated #0: 27 -->
en:brimonidine tartrate
n1=en:tiamenidine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=27
- en:6-cyano-7-nitroquinoxaline-2,3-dione ---
r_associated #0: 26 -->
en:brimonidine tartrate
n1=en:6-cyano-7-nitroquinoxaline-2,3-dione | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=26
- en:biotin-containing product ---
r_associated #0: 26 -->
en:brimonidine tartrate
n1=en:biotin-containing product | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=26
- en:bos taurus hip joint preparation ---
r_associated #0: 26 -->
en:brimonidine tartrate
n1=en:bos taurus hip joint preparation | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=26
- en:brimonidine tartrate 2 mg/ml / timolol 5 mg/ml ophthalmic solution [combigan] ---
r_associated #0: 26 -->
en:brimonidine tartrate
n1=en:brimonidine tartrate 2 mg/ml / timolol 5 mg/ml ophthalmic solution [combigan] | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=26
- en:norepinephrine, dl- ---
r_associated #0: 26 -->
en:brimonidine tartrate
n1=en:norepinephrine, dl- | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=26
- en:norfenefrine ---
r_associated #0: 25 -->
en:brimonidine tartrate
n1=en:norfenefrine | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=25
- en:phenylephrine bitartrate ---
r_associated #0: 25 -->
en:brimonidine tartrate
n1=en:phenylephrine bitartrate | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=25
- en:tetrahydrozoline ---
r_associated #0: 25 -->
en:brimonidine tartrate
n1=en:tetrahydrozoline | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=25
- en:medicinal allergy ---
r_associated #0: 23 -->
en:brimonidine tartrate
n1=en:medicinal allergy | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=23
- agonistes du récepteur alpha-1 adrénergique ---
r_associated #0: 10 -->
en:brimonidine tartrate
n1=agonistes du récepteur alpha-1 adrénergique | n2=en:brimonidine tartrate | rel=r_associated | relid=0 | w=10
|